Table 3.
Countries | Utilisation of CCS services, % | Degree of inequalities | Sources | ||||
---|---|---|---|---|---|---|---|
Poorest (Q1) | Richest (Q5) | RPD | RPR | (Q5-Q1) / Q5 | Conc.I | ||
Present study findings (18 RCCs) | 18.76 | 40.19 | 21.43 | 2.14 | 0.53 | 0.298 | Present study |
Austria | 68.40 | 91.80 | 23.40 | 1.34 | 0.25 | 0.315 | [36] |
Australia | 50.40 | 62.10 | 11.70 | 1.23 | 0.19 | 0.126 | [55] |
Brazil | 55.40 | 88.40 | 33.00 | 1.60 | 0.37 | 0.296 | [36] |
Denmark | 45.00 | 78.00 | 33.00 | 1.73 | 0.42 | 0.098 | [56] |
France | 42.50 | 80.10 | 37.60 | 1.88 | 0.47 | 0.269 | [36] |
Finland | 49.90 | 74.10 | 24.20 | 1.48 | 0.33 | 0.122 | [36] |
Germany | 68.30 | 80.50 | 12.20 | 1.18 | 0.15 | 0.139 | [36] |
Greece | 31.40 | 62.40 | 31.00 | 1.99 | 0.50 | 0.266 | [36] |
Hungary | 38.60 | 78.30 | 39.70 | 2.03 | 0.51 | 0.285 | [36] |
Italy | 72.10 | 69.90 | −2.20 | 0.97 | −0.03 | 0.061 | [36] |
Ireland | 19.90 | 45.50 | 25.60 | 2.29 | 0.56 | 0.220 | [36] |
Luxembourg | 79.20 | 88.90 | 9.70 | 1.12 | 0.11 | 0.243 | [36] |
Mexico | 57.30 | 69.60 | 12.30 | 1.21 | 0.18 | 0.119 | [36] |
Netherlands | 46.40 | 65.90 | 19.50 | 1.42 | 0.30 | 0.151 | [36] |
Paraguay | 32.40 | 71.00 | 38.60 | 2.19 | 0.54 | 0.314 | [36] |
Portugal | 18.70 | 71.30 | 52.60 | 3.81 | 0.74 | 0.318 | [36] |
Russia | 60.50 | 77.00 | 16.50 | 1.27 | 0.21 | 0.142 | [36] |
Spain | 44.00 | 72.30 | 28.30 | 1.64 | 0.39 | 0.207 | [36] |
Slovenia | 62.50 | 78.40 | 15.90 | 1.25 | 0.20 | 0.273 | [36] |
Sweden | 62.50 | 75.80 | 13.30 | 1.21 | 0.18 | 0.177 | [36] |
Slovakia | 47.00 | 70.10 | 23.10 | 1.49 | 0.33 | 0.208 | [36] |
Uruguay | 48.10 | 75.50 | 27.40 | 1.57 | 0.36 | 0.246 | [36] |
UK | 56.80 | 63.40 | 6.60 | 1.12 | 0.10 | 0.069 | [36] |
Note: CCS cervical cancer screening, RCCs resource-constrained countries, HICs high-income countries, Q1 poorest socio-economic status, Q5 richest socio-economic status, RPR rich-poor ratio (Q5/Q1), RPD rich-poor difference (Q5-Q1), Conc. I Concentration Index